项目编号 PRJCA018959
项目标题 A Three-Arm, Randomised, Double-Blind, Multicentre, Phase III Clinical Study in First-Line Treatment of NSCLC
涉及领域 Medical
数据类型 Genetic mutation result and biomarker
物种名称 Homo sapiens
描述信息 HLX10-002-NSCLC301:A Three-Arm, Randomised, Double-Blind, Multicentre, Phase III Clinical Study to Evaluate HLX10 (Recombinant Humanised Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus HLX10 + HLX04 (Recombinant Anti-VEGF Humanised Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Pemetrexed) Versus Chemotherapy (Carboplatin-Pemetrexed) as First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC).The purpose of this study was to evaluate the clinical efficacy, safety, and tolerability of HLX10 combined chemotherapy and HLX10+HLX04 combined chemotherapy versus chemotherapy in subjects who had not previously received systemic treatment for advanced non-squamous NSCLC, collect PK parameters, and explore biomarkers related to efficacy.
样品范围 Multiisolate
发布日期 2023-08-13
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
No funding support
提交者 Yuankai  Shi (syuankaipumc@126.com)
提交单位 National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
提交日期 2023-08-10

项目包含数据信息

资源名称 描述